Which has better valuation & earnings, CVRX or STIM?

Neuronetics has higher revenue and earnings than CVRx. Neuronetics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 0.64 -$53.31M -$1.98 N/A Neuronetics $149.16M 1.02 -$39M -$0.44 N/A

Is CVRX or STIM more profitable?

Neuronetics has a net margin of -19.62% compared to CVRx's net margin of -84.93%. Neuronetics' return on equity of -125.11% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Neuronetics -19.62% -125.11% -22.15%

Does the media prefer CVRX or STIM?

In the previous week, CVRx and CVRx both had 2 articles in the media. Neuronetics' average media sentiment score of 1.18 beat CVRx's score of 0.65 indicating that Neuronetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neuronetics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, CVRX or FOCL?

FocalTherics has higher revenue and earnings than CVRx. FocalTherics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 0.64 -$53.31M -$1.98 N/A FocalTherics $70.53M 2.23 -$29.25M -$1.03 N/A

Is CVRX or FOCL more profitable?

FocalTherics has a net margin of -56.26% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% FocalTherics -56.26% -248.00% -44.69%

Does the media refer more to CVRX or FOCL?

In the previous week, FocalTherics had 2 more articles in the media than CVRx. MarketBeat recorded 4 mentions for FocalTherics and 2 mentions for CVRx. FocalTherics' average media sentiment score of 1.22 beat CVRx's score of 0.65 indicating that FocalTherics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FocalTherics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ZJYL or CVRX?

CVRx has a consensus price target of $4.30, suggesting a potential upside of 216.18%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CVRx 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Which has better earnings and valuation, ZJYL or CVRX?

Jin Medical International has higher earnings, but lower revenue than CVRx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 16.21 $1.19M N/A N/A CVRx $56.65M 0.64 -$53.31M -$1.98 N/A

Do analysts rate CVRX or INGN?

CVRx presently has a consensus target price of $4.30, indicating a potential upside of 216.18%. Given CVRx's higher probable upside, equities research analysts clearly believe CVRx is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has stronger earnings & valuation, CVRX or INGN?

Inogen has higher revenue and earnings than CVRx. Inogen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 0.64 -$53.31M -$1.98 N/A Inogen $348.67M 0.48 -$22.75M -$0.90 N/A

Is CVRX or INGN more profitable?

Inogen has a net margin of -6.94% compared to CVRx's net margin of -84.93%. Inogen's return on equity of -13.17% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Inogen -6.94% -13.17% -8.36%

Does the media prefer CVRX or INGN?

In the previous week, Inogen had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for Inogen and 2 mentions for CVRx. CVRx's average media sentiment score of 0.65 beat Inogen's score of 0.61 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inogen 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, OWLT or CVRX?

Owlet has higher revenue and earnings than CVRx. Owlet is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.28 -$39.68M -$0.75 N/A CVRx $56.65M 0.64 -$53.31M -$1.98 N/A

Is OWLT or CVRX more profitable?

Owlet has a net margin of -8.61% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% CVRx -84.93% -152.35% -50.93%

Does the media favor OWLT or CVRX?

In the previous week, Owlet had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for Owlet and 2 mentions for CVRx. Owlet's average media sentiment score of 1.09 beat CVRx's score of 0.65 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CVRx (CVRX) Competitors

$1.34 -0.02 (-1.47%)

As of 12:04 PM Eastern

Compare

CVRX vs. STIM, FOCL, ZJYL, INGN, and OWLT

Should you buy CVRx stock or one of its competitors? CVRx's main competitors and comparable companies include Neuronetics (STIM), FocalTherics (FOCL), Jin Medical International (ZJYL), Inogen (INGN), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does CVRx compare to Neuronetics?

CVRx (NASDAQ:CVRX) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

75.3% of CVRx shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 8.4% of Neuronetics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Neuronetics has a net margin of -19.62% compared to CVRx's net margin of -84.93%. Neuronetics' return on equity of -125.11% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Neuronetics	-19.62%	-125.11%	-22.15%

CVRx currently has a consensus price target of $4.30, suggesting a potential upside of 216.18%. Neuronetics has a consensus price target of $4.67, suggesting a potential upside of 134.51%. Given CVRx's higher possible upside, analysts plainly believe CVRx is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, CVRx and CVRx both had 2 articles in the media. Neuronetics' average media sentiment score of 1.18 beat CVRx's score of 0.65 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neuronetics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CVRx has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Neuronetics has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Neuronetics has higher revenue and earnings than CVRx. Neuronetics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	0.64	-$53.31M	-$1.98	N/A
Neuronetics	$149.16M	1.02	-$39M	-$0.44	N/A

Summary

Neuronetics beats CVRx on 11 of the 15 factors compared between the two stocks.

How does CVRx compare to FocalTherics?

CVRx (NASDAQ:CVRX) and FocalTherics (NASDAQ:FOCL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

CVRx currently has a consensus target price of $4.30, indicating a potential upside of 216.18%. FocalTherics has a consensus target price of $7.75, indicating a potential upside of 84.52%. Given CVRx's higher possible upside, research analysts plainly believe CVRx is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

CVRx has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, FocalTherics has a beta of -0.06, indicating that its share price is 106% less volatile than the broader market.

FocalTherics has a net margin of -56.26% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
FocalTherics	-56.26%	-248.00%	-44.69%

FocalTherics has higher revenue and earnings than CVRx. FocalTherics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	0.64	-$53.31M	-$1.98	N/A
FocalTherics	$70.53M	2.23	-$29.25M	-$1.03	N/A

In the previous week, FocalTherics had 2 more articles in the media than CVRx. MarketBeat recorded 4 mentions for FocalTherics and 2 mentions for CVRx. FocalTherics' average media sentiment score of 1.22 beat CVRx's score of 0.65 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
FocalTherics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.3% of CVRx shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 10.1% of FocalTherics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

FocalTherics beats CVRx on 10 of the 16 factors compared between the two stocks.

How does CVRx compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Jin Medical International has higher earnings, but lower revenue than CVRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	16.21	$1.19M	N/A	N/A
CVRx	$56.65M	0.64	-$53.31M	-$1.98	N/A

Jin Medical International has a beta of 7.4, meaning that its stock price is 640% more volatile than the broader market. Comparatively, CVRx has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

75.3% of CVRx shares are held by institutional investors. 16.6% of CVRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Jin Medical International has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Jin Medical International's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
CVRx	-84.93%	-152.35%	-50.93%

In the previous week, CVRx had 1 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 1.25 beat CVRx's score of 0.65 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Overall Sentiment
Jin Medical International	Positive
CVRx	Positive

CVRx has a consensus price target of $4.30, suggesting a potential upside of 216.18%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Jin Medical International and CVRx tied by winning 7 of the 14 factors compared between the two stocks.

How does CVRx compare to Inogen?

CVRx (NASDAQ:CVRX) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Inogen has a net margin of -6.94% compared to CVRx's net margin of -84.93%. Inogen's return on equity of -13.17% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Inogen	-6.94%	-13.17%	-8.36%

CVRx presently has a consensus target price of $4.30, indicating a potential upside of 216.18%. Given CVRx's higher probable upside, equities research analysts clearly believe CVRx is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Inogen had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for Inogen and 2 mentions for CVRx. CVRx's average media sentiment score of 0.65 beat Inogen's score of 0.61 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inogen	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.3% of CVRx shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 16.6% of CVRx shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

CVRx has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Inogen has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

Inogen has higher revenue and earnings than CVRx. Inogen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	0.64	-$53.31M	-$1.98	N/A
Inogen	$348.67M	0.48	-$22.75M	-$0.90	N/A

Summary

Inogen beats CVRx on 11 of the 16 factors compared between the two stocks.

How does CVRx compare to Owlet?

Owlet (NYSE:OWLT) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

Owlet currently has a consensus price target of $15.00, suggesting a potential upside of 225.03%. CVRx has a consensus price target of $4.30, suggesting a potential upside of 216.18%. Given Owlet's stronger consensus rating and higher probable upside, analysts plainly believe Owlet is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Owlet has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market. Comparatively, CVRx has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

Owlet has higher revenue and earnings than CVRx. Owlet is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.28	-$39.68M	-$0.75	N/A
CVRx	$56.65M	0.64	-$53.31M	-$1.98	N/A

Owlet has a net margin of -8.61% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
CVRx	-84.93%	-152.35%	-50.93%

72.6% of Owlet shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 16.6% of CVRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Owlet had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for Owlet and 2 mentions for CVRx. Owlet's average media sentiment score of 1.09 beat CVRx's score of 0.65 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Owlet beats CVRx on 13 of the 16 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CVRX vs. The Competition

Export

Metric	CVRx	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$35.70M	$5.54B	$7.28B	$13.01B
Dividend Yield	N/A	1.75%	2.51%	22.89%
P/E Ratio	-0.68	25.47	275.44	25.42
Price / Sales	0.63	65.45	559.80	78.81
Price / Cash	N/A	32.25	77.16	53.04
Price / Book	0.89	5.79	10.66	5.96
Net Income	-$53.31M	$146.14M	$3.50B	$380.62M
7 Day Performance	-19.76%	-2.06%	-3.65%	-3.75%
1 Month Performance	-55.33%	-4.61%	-8.06%	-6.62%
1 Year Performance	-85.59%	0.59%	2.58%	-4.38%

CVRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CVRX CVRx	3.9836 of 5 stars	$1.34 -1.5%	$4.30 +220.9%	-85.0%	$35.70M	$56.65M	N/A	223	Gap Down
STIM Neuronetics	3.5562 of 5 stars	$2.21 +0.5%	$4.67 +111.2%	-27.9%	$168.40M	$155.10M	N/A	658	Positive News
FOCL FocalTherics	4.4372 of 5 stars	$4.27 +0.9%	$7.75 +81.5%	N/A	$160.25M	$79.31M	N/A	230	Positive News
ZJYL Jin Medical International	1.275 of 5 stars	$1.99 +0.5%	N/A	-74.1%	$156.08M	$19.73M	N/A	273	Positive News Gap Down
INGN Inogen	1.0549 of 5 stars	$5.77 -2.9%	N/A	-21.1%	$153.14M	$348.67M	N/A	753

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CVRX) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CVRx (CVRX) Competitors